Millennium looks within to strengthen drug pipeline

11/16/2007 | Reuters

Millennium Pharmaceuticals will focus on expanding its existing drug pipeline instead of aggressively pursuing new drug acquisitions, at the request of shareholders, CEO Deborah Dunsire said Thursday. Millennium is working to pitch its experimental atherosclerosis antibody to potential partners, as well as expanding sales of its multiple myeloma treatment Velcade.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX